The Medical Device Manufacturers Association -MDMA (a US-based trade association that represents hundreds of innovative medtech companies) supports the EU Commissions efforts to streamline, simplify and reduce the time and cost for bringing safe and effective MDR and IVDR medical innovations to hospitals, doctors and patients across the EU. This is both a critical and noble goal.
MDM
Medical Device Manufacturers Association (MDMA
Industry association · United States · EU Transparency Register 991141248676-03
2
positions filed
in the 665 files tracked
1
legislative file
of 665 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1518 trade and business associations on this site, they rank #1194 by legislative files engaged, a count of participation, not a measure of influence.
0.1
declared lobbying FTE
self-declared
€10K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2023
in the register since
- Register category
- Trade and business associations
- Registered as
- Medical Device Manufacturers Association (MDMA)
- Head office
- Washington, DC, United states
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Medical in PolicySpeak: request access →
Work at Medical Device Manufacturers Association (MDMA? so we know who speaks for it.
Their record over time
Medical Device Manufacturers Association (MDMA filed 2 positions between 6 Oct 2025 and 21 Feb 2026, across 1 of the 665 legislative files tracked here, attaching a full position paper 1 time.
2025 · 1 filed2026 · 1 filed
What they argued
Call for Evidence MDR / IVDR: Comments from MDMA (Medical Device Manufacturers Association) based in Washington DC with regulatory advisor in Brussels. MDMA welcomes the opportunity to submit evidence. The new regulatory framework should address the problems with the current system, which especially impact SMEs, as follows: -There should be recognition of the predominance of SME participation in the medtech sector.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Medical Device Manufacturers Association (MDMA next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from Medical Device Manufacturers Association (MDMA’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.